Skip to main content

Table 1 Clinical characteristics

From: Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study

Items

Before IPTW

After IPTW

FPX (N = 1177)

LMWH (N = 1252)

SMD

FPX

LMWH

SMD

Demographic characteristics

 Age (years), mean ± SD

60.3 ± 16.4

61.1 ± 14.5

0.051

60.9 ± 15.8

60.8 ± 15.0

0.009

 Male, No. (%)

510 (43.3)

498 (39.8)

0.072

40.5

42.2

0.033

 Height (cm), mean ± SD

163.8 ± 8.3

162.7 ± 8.6

0.133

163.2 ± 8.3

163.3 ± 8.7

0.004

 Weight (Kg), mean ± SD

65.2 ± 11.4

65.7 ± 11.7

0.040

65.4 ± 11.4

65.5 ± 11.9

0.004

 BMI (Kg/m2), mean ± SD

24.3 ± 3.7

24.8 ± 3.9

0.137

24.6 ± 3.8

24.6 ± 3.9

0.001

Risk factors, No. (%)

 History of bleeding

21 (1.8)

19 (1.5)

0.021

1.7

1.8

0.008

 History of hypertension

402 (34.2)

451 (36.0)

0.039

35.4

35.3

0.002

 History of diabetes mellitus

93 (7.9)

111 (8.9)

0.035

8.1

9.0

0.031

 History of surgery

292 (24.8)

353 (28.2)

0.077

25.2

27.5

0.052

 Major surgery within one month

5 (0.4)

3 (0.2)

0.032

0.4

0.3

0.024

 Other risk factors

1177 (100.0)

1252 (100.0)

< 0.001

100.0

100.0

< 0.001

 DVT score, mean ± SD

10.2 ± 4.1

9.7 ± 3.9

0.145

10.0 ± 3.9

10.0 ± 4.1

0.002

Vital signs, mean ± SD

 DBP (mmHg)

78.6 ± 11.2

78.0 ± 10.7

0.057

78.8 ± 11.3

77.8 ± 10.8

0.091

 SBP (mmHg)

136.0 ± 17.8

135.6 ± 17.0

0.022

136.4 ± 17.7

135.2 ± 17.1

0.069

 HR (times/min)

79.4 ± 8.9

79.2 ± 8.8

0.016

79.3 ± 8.8

79.4 ± 9.0

0.012

Laboratory indexes, mean ± SD

 HB (g/L)

128.4 ± 15.6

128.5 ± 14.9

0.001

128.5 ± 15.4

128.5 ± 15.2

0.002

 PLT (X109/L)

233.1 ± 71.6

239.1 ± 74.1

0.082

236.3 ± 73.4

236.4 ± 72.7

0.002

 PT (s)

12.8 ± 5.2

12.6 ± 5.4

0.044

12.8 ± 5.5

12.9 ± 8.1

0.017

 aPTT (s)

30.5 ± 7.1

30.3 ± 8.4

0.032

30.8 ± 7.6

30.3 ± 8.1

0.054

 TT (s)

18.7 ± 8.0

18.5 ± 2.5

0.034

18.6 ± 7.0

18.5 ± 2.5

0.005

 D-dimer (mg/L)

5.8 ± 12.4

4.6 ± 11.7

0.096

5.2 ± 11.8

5.1 ± 12.1

0.002

 INR

1.1 ± 0.9

1.2 ± 3.1

0.078

1.1 ± 1.0

1.2 ± 3.0

0.077

 PTA (%)

106.1 ± 19.3

108.3 ± 37.7

0.071

106.7 ± 19.4

106.8 ± 33.6

0.003

 FIB (g/L)

2.9 ± 0.8

3.0 ± 0.8

0.095

3.0 ± 0.8

3.0 ± 0.8

0.006

 Scr (μmol/L)

71.2 ± 40.2

70.8 ± 45.9

0.008

71.0 ± 39.9

71.0 ± 46.0

0.001

 Ccr (mL/min)

102.5 ± 38.6

101.4 ± 36.6

0.031

101.8 ± 37.6

101.8 ± 37.1

< 0.001

Type of surgery, No. (%)

 Hip fracture

186 (15.8)

156 (12.5)

0.096

14.1

14.0

0.001

 Hip replacement

160 (13.6)

201 (16.1)

0.069

14.8

14.8

0.002

 Knee replacement

296 (25.1)

453 (36.2)

0.241

30.8

30.8

< 0.001

 Upper limb surgery

37 (3.1)

7 (0.6)

0.193

1.8

1.6

0.018

 Other trauma surgery

465 (39.5)

429 (34.3)

0.109

37.0

37.1

0.003

 No surgery

72 (6.1)

54 (4.3)

0.081

5.2

5.3

0.001

Type of anesthesia, No. (%)

 General anesthesia

357 (30.3)

285 (22.8)

0.172

26.3

26.0

0.007

 Regional anesthesia

691 (58.7)

847 (67.7)

0.186

63.4

63.7

0.007

 Local anesthesia

17 (1.4)

20 (1.6)

0.013

1.6

1.4

0.012

 Combined anesthesia

18 (1.5)

16 (1.3)

0.021

1.6

1.3

0.031

 No anesthesia

94 (8.0)

84 (6.7)

0.049

7.1

7.6

0.020

 Duration of surgery (hours), mean ± SD

1.9 ± 1.1

1.8 ± 0.9

0.181

1.8 ± 1.0

1.9 ± 1.1

0.007

 Duration of anesthesia (hours), mean ± SD

3.6 ± 24.5

3.0 ± 19.5

0.031

3.4 ± 22.7

4.0 ± 28.7

0.021

 Duration of medication (days), mean ± SD

8.1 ± 12.2

7.5 ± 11.5

0.050

7.7 ± 11.7

7.8 ± 12.7

0.009

 HLOS (days), mean ± SD

10.9 ± 6.4

10.9 ± 5.6

0.007

10.7 ± 5.9

11.0 ± 6.2

0.054

  1. IPTW inverse-probability-of-treatment weighting method, FPX fondaparinux sodium, LMWH low molecular weight heparins, SMD standardized mean difference, SD standard deviation, BMI body mass indexes, DVT deep vein thrombosis, DBP diastolic blood pressure, SBP systolic blood pressure, HR heart rate, HB hemoglobin, PLT platelet, PT prothrombin time, aPTT activated partial thromboplastin time, TT thrombin time, INR international normalized ratio, PTA prothrombin time activity, FIB fibrinogen Scr serum creatinine, Ccr creatinine clearance rate, HLOS hospital length of stay